In this podcast episode of the Life Sciences WA Podcast, the guest was Bronwyn LeGrice, CEO of ANDHealth. The focus of the discussion was on investing and commercialising digital health. LeGrice introduced herself and discussed her background, which included seven years in venture capital and over 20 years in the commercialisation of medical technologies, including setting up and Health. She explained that ANDHealth is Australia's only dedicated digital health commercialisation company. When asked to define digital health, LeGrice said that it is the application of technology and software with or without connected devices to change the healthcare paradigm. She emphasised that at and Health, they focus on what they call "evidence-based digital health", or digital health where clinical and/or commercial evidence is required to enable a technology to make it to market. LeGrice also discussed the potential for digital health to improve the efficiency of the healthcare system, and how ANDHealth helps companies in the digital health space to be investment ready. She stressed the importance of having a solid business plan and a strong team, as well as understanding the regulatory landscape. Overall, the discussion highlighted the potential for investment in the digital health space, and the importance of commercialising technologies with clinical and commercial evidence in order to bring them to market.